BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9159562)

  • 1. Pharmacokinetic and pharmacodynamic interaction trial after repeated oral doses of imidapril and digoxin in healthy volunteers.
    Harder S; Thürmann PA
    Br J Clin Pharmacol; 1997 May; 43(5):475-80. PubMed ID: 9159562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1997; 51(6):489-91. PubMed ID: 9112065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A saturable tissue-angiotensin I converting enzyme (ACE) binding model for the pharmacokinetic analysis of imidapril, a new ACE inhibitor, and its active metabolite in human.
    Tagawa K; Mizobe M; Noda K
    Biol Pharm Bull; 1995 Jan; 18(1):64-9. PubMed ID: 7735253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic study of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor, in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Biomed Anal; 1997 Aug; 15(12):1851-9. PubMed ID: 9278890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
    Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
    J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure.
    Hoogkamer JF; Kleinbloesem CH; Nokhodian A; Ouwerkerk MJ; Lankhaar G; Ungethüm W; Kirch W
    Eur J Clin Pharmacol; 1998 Mar; 54(1):59-61. PubMed ID: 9591932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats.
    Yamanaka K; Takehara N; Murata K; Banno K; Sato T
    J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
    van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
    J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
    Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
    Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
    De Smet M; Schoors DF; De Meyer G; Verbesselt R; Goldberg MR; Fitzpatrick V; Somers G
    Br J Clin Pharmacol; 1995 Dec; 40(6):571-5. PubMed ID: 8703664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No pharmacokinetic or pharmacodynamic interaction between digoxin and the oral direct thrombin inhibitor ximelagatran in healthy volunteers.
    Sarich TC; Schützer KM; Wollbratt M; Wall U; Kessler E; Eriksson UG
    J Clin Pharmacol; 2004 Aug; 44(8):935-41. PubMed ID: 15286098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of imidapril and imidaprilat in human plasma by high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
    Mabuchi M; Kano Y; Fukuyama T; Kondo T
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 734(1):145-53. PubMed ID: 10574200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic, regional and cerebral hemodynamic effects of a new angiotensin converting enzyme inhibitor, imidapril, in healthy volunteers.
    Démolis P; Annane D; Duhazé P; Giudicelli JF
    Fundam Clin Pharmacol; 1994; 8(1):80-9. PubMed ID: 8181800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 6th communication: interspecies comparison of pharmacokinetics and excretion of imidapril metabolites in rats, dogs, and monkeys.
    Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1992 Apr; 42(4):499-506. PubMed ID: 1642673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose finding studies with imidapril--a new ACE inhibitor.
    Vandenburg MJ; Mackay EM; Dews I; Pullan T; Brugier S
    Br J Clin Pharmacol; 1994 Mar; 37(3):265-72. PubMed ID: 8198936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of imidapril on He-Ne laser-induced thrombosis in cerebral blood vessels of stroke-prone spontaneously hypertensive rats.
    Sasaki Y; Noguchi T; Seki J; Giddings JC; Yamamoto J
    Thromb Haemost; 2000 May; 83(5):722-7. PubMed ID: 10823269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.